United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2003_register executive 2010-09-23 article Rules and Regulations D09002ee1c8181a67 D09002ee1c8181b63 United States Department of Health and Human Services originator org United States Government Agency or Subagency United States Food and Drug Administration originator org United States Government Agency or Subagency The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of February 6, 2003 (68 FR 6062). The document amended FDA's regulations to require that the labeling for all systemic antibacterial drug products intended for human use include certain statements about using antibiotics in a way that will reduce the development of drug-resistant bacterial strains. The document was published with an inadvertent error. This document corrects that error. 68 FR 12584 https://www.govinfo.gov/app/details/FR-2003-03-17/03-6232 03-6232 fr17mr03-6 RIN 0910-AB78 4160-01-S Docket No. 00N-1463 https://www.govinfo.gov/app/details/FR-2003-03-17/03-6232 https://www.govinfo.gov/content/pkg/FR-2003-03-17/html/03-6232.htm https://www.govinfo.gov/content/pkg/FR-2003-03-17/pdf/03-6232.pdf 1 p. 12584 12584 68 FR 12584 Title 21 Part 201 21 CFR Part 201 RIN 0910-AB78 Labeling Requirements for Systemic Antibacterial Drug Products Intended for Human Use; Correction; Federal Register Vol. 68, Issue RULE 03-6232 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Docket No. 00N-1463 4160-01-S 03-6232 Final rule; correction.

The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of February 6, 2003 (68 FR 6062). The document amended FDA's regulations to require that the labeling for all systemic antibacterial drug products intended for human use include certain statements about using antibiotics in a way that will reduce the development of drug-resistant bacterial strains. The document was published with an inadvertent error. This document corrects that error.

Joyce Strong, Office of Policy (HF- 27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010. Human drugs: Systemic antibacterial products; labeling requirements Correction, Vol. 68, no. 51 Office of the Federal Register, National Archives and Records Administration 2003-03-17 continuing daily deposited born digital 242 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2003-03-17 P0b002ee1809cefe5 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr17mr03 https://www.govinfo.gov/app/details/FR-2003-03-17 https://www.govinfo.gov/content/pkg/FR-2003-03-17/pdf/FR-2003-03-17.pdf https://www.govinfo.gov/content/pkg/FR-2003-03-17/xml/FR-2003-03-17.xml fdlp 12569 12795 DGPO 2010-09-23 2024-06-07 FR-2003-03-17 machine generated eng FR FR-2003-03-17 68 51